down arrow

Windlas Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0H5O01029
  • NSEID: WINDLAS
  • BSEID: 543329
INR
960.45
63.55 (7.09%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 51.24 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
557.17
459.67
372.37
343.80
320.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
557.17
459.67
372.37
343.80
320.80
Raw Material Cost
378.28
279.98
248.28
230.53
197.43
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-31.62
9.05
-11.70
-7.18
5.92
Employee Cost
90.99
64.61
52.09
46.82
41.78
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
50.97
49.88
39.91
35.04
32.08
Total Expenditure (Excl Depreciation)
488.62
403.51
328.58
305.21
277.21
Operating Profit (PBDIT) excl Other Income
68.55
56.16
43.79
38.59
43.59
Other Income
13.08
9.02
7.63
3.70
2.30
Operating Profit (PBDIT)
81.63
65.18
51.42
42.29
45.89
Interest
3.06
0.83
0.63
1.13
0.97
Exceptional Items
0.00
0.00
0.00
0.00
-21.62
Gross Profit (PBDT)
78.57
64.35
50.79
41.16
23.30
Depreciation
19.65
9.91
8.80
9.25
9.61
Profit Before Tax
58.94
54.46
42.00
31.91
13.69
Tax
14.22
13.27
10.82
8.61
3.84
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
44.72
41.20
31.18
23.30
9.84
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
44.72
41.20
31.18
23.30
9.84
Share in Profit of Associates
0.00
0.00
0.00
0.00
-0.17
Minority Interest
0.00
0.00
0.00
0.00
0.26
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
44.72
41.20
31.18
23.30
9.94
Equity Capital
10.45
10.40
10.72
10.90
10.90
Face Value
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
7.38
7.26
4.23
3.81
6.75
Operating Profit Margin (Excl OI)
12.3%
12.22%
11.76%
11.22%
13.59%
Gross Profit Margin
14.1%
14.0%
13.64%
11.97%
7.26%
PAT Margin
8.03%
8.96%
8.37%
6.78%
3.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is 21.21% vs 23.44% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2024 is 8.54% vs 32.14% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is 22.06% vs 28.25% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is 268.67% vs 31.75% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has improved from Dec 2023

Compare Nine Monthly Results Of Windlas Biotech With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
557.17
9,199.93
-8,642.76
-93.94%
Other Operating Income
0.00
0.00
0.00
Total Operating income
557.17
9,199.93
-8,642.76
-93.94%
Raw Material Cost
378.28
1,471.08
-1,092.80
-74.29%
Purchase of Finished goods
0.00
1,244.57
-1,244.57
-100.00%
(Increase) / Decrease In Stocks
-31.62
-93.01
61.39
66.00%
Employee Cost
90.99
1,989.92
-1,898.93
-95.43%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
50.97
2,225.77
-2,174.80
-97.71%
Total Expenditure (Excl Depreciation)
488.62
6,838.33
-6,349.71
-92.85%
Operating Profit (PBDIT) excl Other Income
68.55
2,361.60
-2,293.05
-97.10%
Other Income
13.08
287.35
-274.27
-95.45%
Operating Profit (PBDIT)
81.63
2,648.95
-2,567.32
-96.92%
Interest
3.06
238.94
-235.88
-98.72%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
78.57
2,410.01
-2,331.44
-96.74%
Depreciation
19.65
405.66
-386.01
-95.16%
Profit Before Tax
58.94
2,007.79
-1,948.85
-97.06%
Tax
14.22
427.80
-413.58
-96.68%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
44.72
1,576.55
-1,531.83
-97.16%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
44.72
1,576.55
-1,531.83
-97.16%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
0.00
-7.70
7.70
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
44.72
1,570.19
-1,525.47
-97.15%
Equity Capital
10.45
40.06
-29.61
-73.91%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
14.10%
26.20%
0.00
-12.10%
PAT Margin
8.03%
17.14%
0.00
-9.11%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 557.17 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 21.21% vs 23.44% in Dec 2023

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 44.72 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 8.54% vs 32.14% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 68.55 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 22.06% vs 28.25% in Dec 2023

Nine Monthly - Interest
Interest 3.06 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 268.67% vs 31.75% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.30%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in nine months ended Dec 2024 has improved from Dec 2023